🇺🇸 2 - Insulin glargine QAM in United States

2 - Insulin glargine QAM (2 - Insulin glargine QAM) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

2 - Insulin glargine QAM in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 2 - Insulin glargine QAM approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 2 - Insulin glargine QAM in United States?

Charles Drew University of Medicine and Science is the originator. The local marketing authorisation holder may differ — check the official source linked above.